Trial finds formula in Releev highly active against herpes
BARRINGTON, Ill. — Merix Pharmaceutical Corp., an industry leader in the treatment of cold sores and development of phyto-pharmaceutical technology, announces its proprietary botanical extract formula Viracea was found to be highly active against HSV-1 and HSV-2 in laboratory testing. In a double-blind, placebo controlled, clinical trial Viracea was found to heal cold sores in
